Acro Biomedical Co., Ltd.
ACBM
$0.0007
-$0.1043-99.33%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 41.10K | 36.60K | 38.00K | 45.90K | 1.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.10K | 36.60K | 38.00K | 45.90K | 1.61M |
| Operating Income | -41.10K | -36.60K | -38.00K | -45.90K | -1.61M |
| Income Before Tax | -46.80K | -41.30K | -42.30K | -49.80K | -1.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.05 | -0.04 | -0.04 | -0.05 | -1.63 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.80K | -41.30K | -42.30K | -49.80K | -1.63M |
| EBIT | -41.10K | -36.60K | -38.00K | -45.90K | -1.61M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| Average Basic Shares Outstanding | 240.17M | 240.17M | 240.17M | 240.17M | 240.17M |
| Average Diluted Shares Outstanding | 240.17M | 240.17M | 240.17M | 240.17M | 240.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |